Key risks
Consolidated OPM of 7.18% is thin; subsidiary margins (4–15%) consistently trail standalone (11–17%), raising questions about subsidiary cost structure — verify where this gap originates and whether management has a plan to narrow it
ROE of just 5.84% paired with PE 34.81 signals the market prices in recovery not yet visible; verify what operational changes or capital initiatives underpin this valuation multiple
Revenue flat at ₹92–94 Cr (consolidated) and ₹18–19 Cr (standalone) over recent quarters with zero institutional ownership (FII 0%, DII 0%) suggests limited external conviction — verify competitive position and pipeline
Stock near 52-week low of ₹25.99 versus price ₹29.68, down 4.84% year-on-year; verify whether recovery depends primarily on top-line growth or margin expansion, and which is likelier
Generated analysis · source review pending